Global Pharmacy Benefit Management Services Market: The increasing cases of chronic diseases are projected to boost market growth at a healthy CAGR of ~5.8% during the forecast period of 2019 to 2024

Technological Integration and Rising Prescription Drug Costs to Drive Pharmacy Benefit Management Services Market to USD 1,024.28 Billion by 2035 at 6.14% CAGR

According to a detailed study by Market Research Future (MRFR), the Global Pharmacy Benefit Management Services Market is projected to grow from USD 531.69 billion in 2024 to USD 1,024.28 billion by 2035, registering a compound annual growth rate (CAGR) of 6.14% during the forecast period (2025–2035). The market growth is primarily driven by the rising costs of prescription drugs, the increasing demand for specialty medicines, and the integration of advanced technologies to enhance efficiency in benefit management.

The key players recognized by MRFR in the global Pharmacy Benefit Management Services Market include CVS Health (US), Express Scripts (US), OptumRx (US), Humana (US), Cigna (US), Prime Therapeutics (US), MedImpact (US), and EnvisionRx (US). These companies are focusing on digital transformation, strategic partnerships, and innovation in benefit design to strengthen their market position globally.

Market Highlights

The Global Pharmacy Benefit Management Services Market is undergoing a transformative shift driven by the growing complexity of healthcare systems and the rising emphasis on cost optimization and transparency. In 2024, the market was valued at USD 531.69 billion and is anticipated to reach USD 1,024.28 billion by 2035, supported by strong demand from health insurers, employers, and public health programs seeking to manage rising medication costs. Pharmacy benefit managers (PBMs) play a crucial role in negotiating drug prices, managing formularies, and ensuring medication accessibility, thereby reducing overall healthcare expenditure.

Technological innovation has emerged as a key differentiator in the market. The adoption of artificial intelligence (AI), machine learning (ML), and data analytics is reshaping PBM operations, enhancing claims management, and improving clinical outcomes. These tools enable PBMs to predict patient adherence risks, monitor drug utilization trends, and provide tailored medication management programs. As a result, PBMs are evolving from cost controllers to strategic healthcare partners focused on improving patient outcomes.

Moreover, the market is being influenced by growing regulatory scrutiny and an increasing focus on pricing transparency. Governments across major markets are introducing new policies to ensure fair competition, prevent excessive markups, and improve access to affordable medicines. The shift toward preventive care and value-based healthcare models is further driving PBMs to innovate their services, integrating telehealth, medication therapy management, and digital adherence tools into their offerings.

Segment Analysis

The Global Pharmacy Benefit Management Services Market is segmented by Service Type (Claims Management, Formulary Management, Drug Utilization Review, Medication Therapy Management), End User (Pharmacies, Health Plans, Employers, Public Sector), Service Provider (Standalone Pharmacy Benefit Managers, Health Insurance Companies, Integrated Health Systems), and Operating Model (Fully-Managed Services, Pass-Through Services, Hybrid Services).

Among service types, Claims Management holds the largest market share due to its critical role in processing large volumes of pharmacy claims efficiently, while Medication Therapy Management is the fastest-growing segment as healthcare systems emphasize personalized and preventive care. Formulary Management also remains a key component, enabling better negotiation and cost control for healthcare payers.

By end user, Health Plans dominate the market owing to their broad member base and established infrastructure for managing prescription benefits. Pharmacies, however, are emerging as the fastest-growing end-user segment as they increasingly integrate digital tools and collaborate directly with PBMs to improve patient engagement and medication adherence.

In terms of service providers, Standalone Pharmacy Benefit Managers lead the market, offering specialized expertise and economies of scale in drug benefit administration. Integrated Health Systems are expanding rapidly, leveraging coordinated healthcare delivery models to provide holistic, patient-centered solutions that combine pharmacy services with broader health management.

By operating model, Fully-Managed Services account for the largest share, offering end-to-end benefit management solutions to clients seeking to outsource administrative functions entirely. Hybrid Services are gaining momentum as organizations seek flexible models that balance autonomy with PBM expertise, providing transparency and customization in contract terms.

Regional Analysis

North America remains the largest market for Pharmacy Benefit Management Services, accounting for approximately 70% of the global market share. High prescription drug spending, a well-established healthcare insurance system, and the presence of leading PBMs such as CVS Health, Express Scripts, and OptumRx support the region’s dominance. The U.S. continues to lead this segment, with a growing emphasis on transparency reforms and the adoption of digital solutions for medication management.

Europe holds the second-largest share, representing nearly 20% of the global market. Growth in this region is fueled by rising healthcare costs and regulatory efforts to improve drug affordability and access. Countries such as Germany, the UK, and France are key markets, where increasing collaboration between insurers, PBMs, and healthcare providers is driving adoption.

Asia-Pacific is the fastest-growing regional market, holding about 8% of the global share. Rapid urbanization, expanding healthcare infrastructure, and a growing prevalence of chronic diseases in China and India are propelling the adoption of PBM services. The focus on improving healthcare efficiency and digitalization of benefit management platforms is expected to accelerate growth in this region.

The Middle East and Africa region, though nascent, holds about 2% of the global market and is showing gradual expansion driven by rising healthcare investments and government initiatives to improve medication access. Countries such as South Africa and the UAE are leading efforts to introduce PBM models within their evolving healthcare systems.

Key Findings of the Study

• The Global Pharmacy Benefit Management Services Market is projected to grow from USD 531.69 billion in 2024 to USD 1,024.28 billion by 2035, at a CAGR of 6.14% during the forecast period.• Rising prescription drug costs, growing demand for specialty drugs, and technological advancements are key market drivers.• Claims Management is the largest service segment, while Medication Therapy Management exhibits the fastest growth.• Health Plans dominate the end-user segment, whereas Pharmacies are rapidly emerging with increased digital adoption.• Standalone Pharmacy Benefit Managers lead among service providers, while Integrated Health Systems are expanding swiftly.• North America remains the largest market, while Asia-Pacific is the fastest-growing region.• Major players such as CVS Health, Express Scripts, and OptumRx are leveraging technology, partnerships, and transparency initiatives to maintain competitive leadership.

Related Report